PRDX2 and hepatocellular carcinoma: It has also been reported that PRDX2 is significantly downregulated in hepatocellular carcinoma (HCC) tissues in terms of both mRNA and protein expression, and that its low expression is suggestive of poor prognosis for HCC patients [11, 12].